Northern Trust’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $175K | Sell |
141,424
-159,462
| -53% | -$198K | ﹤0.01% | 3978 |
|
2025
Q1 | $367K | Sell |
300,886
-12,952
| -4% | -$15.8K | ﹤0.01% | 3701 |
|
2024
Q4 | $565K | Buy |
313,838
+21,227
| +7% | +$38.2K | ﹤0.01% | 3614 |
|
2024
Q3 | $1.49M | Buy |
292,611
+246,934
| +541% | +$1.26M | ﹤0.01% | 3165 |
|
2024
Q2 | $325K | Buy |
45,677
+2,209
| +5% | +$15.7K | ﹤0.01% | 3665 |
|
2024
Q1 | $119K | Sell |
43,468
-5,244
| -11% | -$14.4K | ﹤0.01% | 4030 |
|
2023
Q4 | $132K | Buy |
48,712
+37,530
| +336% | +$101K | ﹤0.01% | 4042 |
|
2023
Q3 | $29.4K | Hold |
11,182
| – | – | ﹤0.01% | 4265 |
|
2023
Q2 | $31.3K | Sell |
11,182
-65
| -0.6% | -$182 | ﹤0.01% | 4322 |
|
2023
Q1 | $32.6K | Sell |
11,247
-247
| -2% | -$716 | ﹤0.01% | 4361 |
|
2022
Q4 | $42.2K | Hold |
11,494
| – | – | ﹤0.01% | 4321 |
|
2022
Q3 | $37K | Hold |
11,494
| – | – | ﹤0.01% | 4407 |
|
2022
Q2 | $35K | Sell |
11,494
-44,087
| -79% | -$134K | ﹤0.01% | 4515 |
|
2022
Q1 | $466K | Sell |
55,581
-5,714
| -9% | -$47.9K | ﹤0.01% | 3767 |
|
2021
Q4 | $641K | Sell |
61,295
-741
| -1% | -$7.75K | ﹤0.01% | 3722 |
|
2021
Q3 | $1.12M | Buy |
+62,036
| New | +$1.12M | ﹤0.01% | 3516 |
|